ANDERSON; Larry J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for ANDERSON; Larry J..The latest application filed is for "rsv virus-like particles and methods of use thereof".

Company Profile

0.16.11

ANDERSON; Larry J. - Atlanta GA
Anderson; Larry J. - Blue Springs MO US
Anderson, Larry J - Atlanta GA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Rsv Virus-like Particles And Methods Of Use Thereof App 20210401969 - HA; Binh ; et al.	2021-12-30
Anti-RSV immunogens and methods of immunization Grant 8,846,056 - Anderson , et al. September 30, 2	2014-09-30
Compositions And Methods For Modulating Rsv Infection And Immunity App 20140288267 - Tripp; Ralph A. ; et al.	2014-09-25
Lung aerosol collection device Grant 8,821,409 - Ku , et al. September 2, 2	2014-09-02
Compositions and methods for modulating RSV infection and immunity Grant 8,778,354 - Tripp , et al. July 15, 2	2014-07-15
Anti-RSV immunogens and methods of immunization Grant 8,771,706 - Anderson , et al. July 8, 2	2014-07-08
Anti-rsv Immunogens And Methods Of Immunization App 20130136759 - Anderson; Larry J. ; et al.	2013-05-30
Foreign track current suppression system and method Grant 8,376,286 - Anderson , et al. February 19, 2	2013-02-19
CD40 ligand adjuvant for respiratory syncytial virus Grant 8,354,115 - Tripp , et al. January 15, 2	2013-01-15
Compositions And Methods For Modulating Rsv Infection And Immunity App 20120258111 - Tripp; Ralph A. ; et al.	2012-10-11
Anti-rsv Immunogens And Methods Of Immunization App 20120148666 - Anderson; Larry J. ; et al.	2012-06-14
Compositions and methods for modulating RSV infection and immunity Grant 8,173,131 - Tripp , et al. May 8, 2	2012-05-08
Lung Aerosol Collection Device App 20120004571 - Ku; David N. ; et al.	2012-01-05
Foreign Track Current Suppression System And Method App 20110309205 - Anderson; Larry J. ; et al.	2011-12-22
Coronavirus isolated from humans Grant 7,776,521 - Rota , et al. August 17, 2	2010-08-17
Cd40 Ligand Adjuvant For Respiratory Syncytial Virus App 20080181915 - Tripp; Ralph A. ; et al.	2008-07-31
Cd40 ligand adjuvant for respiratory syncytial virus Grant 7,371,392 - Tripp , et al. May 13, 2	2008-05-13
Coronavirus isolated from humans Grant 7,220,852 - Rota , et al. May 22, 2	2007-05-22
Method for the prevention and treatment of diseases caused by an inflammatory response mediated by endogenous substance P by using anti-substance P antibodies Grant 7,101,547 - Tripp , et al. September 5, 2	2006-09-05
Compositions and methods for modulating RSV infection and immunity App 20060018925 - Tripp; Ralph A. ; et al.	2006-01-26
Compositions and methods for modulating RSV infection and immunity App 20040009177 - Tripp, Ralph A. ; et al.	2004-01-15
Cd40 ligand adjuvant for respiratory syncytial virus App 20030021808 - Tripp, Ralph A ; et al.	2003-01-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.